It has previously been shown that SYK activation occurs following ANCA-induced neutrophil activation,8 suggesting that SYK inhibition may be a potential therapeutic approach in AAV, though in vivo data are lacking. Here, SYK is linked to anti-neutrophil cytoplasmic antibody-associated vasculitis.